Wacker and Pantherna intensify collaboration in the development and production of mRNA biopharmaceuticals
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
Subscribe To Our Newsletter & Stay Updated